Method for purifying vildagliptin
Through a multi-step purification method, the problem of low purity in the existing vidagliptin synthesis method is solved, and high purity and high yield of vidagliptin preparation is achieved, which enhances the market competitiveness of the product.
Patent Information
- Application Number
- CN202310619034.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-30
- Publication Date
- 2024-12-03
AI Technical Summary
The existing vidagliptin synthesis method has difficulty monitoring the reaction and many by-products, resulting in low purity of the product, difficult to meet the medicinal requirements, and lack of market competitive advantages.
A multi-step purification method is adopted: heating the organic solvent and organic base in the reaction flask, adding 3-amino-1-adamantanol and (S)-1-(2-chloroacetyl)pyrrole-2-formitrile , the treatment was carried out under reduced pressure distillation and adsorption, followed by adding a desiccant and drying in vacuo, and finally vigagliptin was obtained by cooling and filtration. The organic solvent and catalyst used in this method can be combined and optimized as needed.
The double-substituted impurities of vigallabel obtained by this method are controlled below 0.10%, which avoids multiple recrystallization and refining, greatly improves the yield, and exceeds 90%.
Smart Images

Figure SMS_1
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biomedicine and related fields, and in particular to a method for purifying vildagliptin. Background Art
[0002] Vildagliptin is a selective DPP4 inhibitor. Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like polypeptide 1 (GLP-1) are important hormones for maintaining glucose concentration in the body, and both have incretin effects. In patients with type II diabetes, the insulinotropic effect of GIP is impaired, and only GLP-1 can play a role in promoting insulin secretion. It promotes insulin secretion by acting on receptors on the pancreatic B cell membrane. Vildagliptin covalently binds to the DPP-4 catalytic site, acts quickly, and dissociates slowly, so it can quickly and persistently increase the level of active GLP-1 in the body, effectively covering mealtime and fasting periods, and is more conducive to patients' glycated blood glucose protein (HbAlc) levels reaching the standard.
[0003] After extensive searching, we found the existing synthesis method of vildagliptin, the main route is as follows:
[0004]
[0005] For example, the invention patent "One-pot preparation of vildagliptin" with publication number CN102617434A introduces a method for synthesizing vildagliptin, which uses chloroacetyl chloride, (S)-1-pyrrolidine-2-carbonitrile and 3-amino-1-adamantanol as raw materials to prepare vildagliptin by a one-pot method. The reaction of this method is not easy to monitor, and many by-products are produced, which puts great pressure on the refining of the finished product, and easily results in low product purity, which is difficult to meet the requirements for pharmaceutical use. Therefore, this process has no market competitive advantage.
[0006] In view of the above-mentioned defects, the inventors of the present invention have actively conducted research and innovation in order to create a purification method for vildagliptin to make it more valuable for industrial use. Summary of the invention
[0007] In order to solve the above technical problems, the object of the present invention is to provide a method for purifying vildagliptin.
[0008] To achieve the above object, the present invention adopts the following technical solution:
[0009] A method for purifying vildagliptin, the purification method comprising the following steps in sequence:
[0010] Step 1, add an organic solvent 1 and an organic base into a reaction bottle, then add 3-amino-1-adamantanol (Formula II) and (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile (Formula III), heat to 40-55° C., react for 10-12 hours, and obtain a reaction solution;
[0011] Step 2, subjecting the reaction solution obtained in the above step 1 to reduced pressure distillation, cooling it to 30-45° C., adding organic solvent 2 and adsorbent, and stirring for 1-2 hours;
[0012] Step 3, after the stirring in the above step 2, the mixture is allowed to stand for stratification, and the filter residue is washed with an organic solvent to obtain an organic phase extract;
[0013] Step 4, adding a desiccant to the organic phase extract obtained in the above step 3 for drying, filtering and concentrating under reduced pressure to obtain a concentrated solution;
[0014] Step 5: Add organic solvent 2 to the concentrated solution obtained in step 4, heat until completely dissolved, cool to 0-3°C for crystallization, filter, and vacuum dry to obtain vildagliptin (Formula I).
[0015] As a further improvement of the present invention, the organic solvent 1 in step 1 is one or a combination of more than one of tetrahydrofuran, dimethylacetamide, dichloromethane, ethyl acetate, methanol and acetone.
[0016] As a further improvement of the present invention, a catalyst is also added to the reaction bottle in step 1, and the catalyst is potassium iodide.
[0017] As a further improvement of the present invention, the organic base in step 1 is one or a combination of more than one of potassium carbonate, triethylamine, tetramethylguanidine and pyridine.
[0018] As a further improvement of the present invention, the molar ratio of 3-amino-1-adamantanol to (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile is 1.0-2.0:0.5-1.2.
[0019] As a further improvement of the present invention, the second organic solvent is one or a combination of more than one of toluene, dichloromethane, chloroform, ethyl acetate, methanol, ethanol, isopropanol, acetone and butanone.
[0020] As a further improvement of the present invention, the adsorbent is one or a combination of more than one of alkaline alumina and silica gel.
[0021] As a further improvement of the present invention, the desiccant is one or a combination of more than one of anhydrous magnesium sulfate, anhydrous sodium sulfate, anhydrous calcium chloride, phosphorus pentoxide, and anhydrous potassium carbonate.
[0022] As a further improvement of the present invention, the vacuum drying conditions in step 5 are: vacuum drying at 40-50° C. for 5-8 hours.
[0023] By means of the above scheme, the present invention has at least the following advantages:
[0024] The vildagliptin finished product obtained by the purification method of the present invention can control the vildagliptin disubstituted impurities to be below 0.10%.
[0025] The invention can avoid multiple recrystallization refining and greatly improve the yield, which is greater than 90%.
[0026] The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention and implement it according to the contents of the specification, the preferred embodiments of the present invention are described in detail as follows. DETAILED DESCRIPTION
[0027] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
[0028] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiment of the present invention will be clearly and completely described below in conjunction with the embodiment of the present invention. Obviously, the described embodiment is only a part of the embodiment of the present invention, rather than all the embodiments. Usually, the components of the embodiment of the present invention shown can be arranged and designed in various different configurations. Therefore, the following detailed description of the embodiment of the present invention provided is not intended to limit the scope of the claimed invention, but merely represents the selected embodiment of the present invention. Based on the embodiment of the present invention, all other embodiments obtained by those skilled in the art without making creative work belong to the scope of protection of the present invention.
[0029] A method for purifying vildagliptin, the purification method comprising the following steps in sequence:
[0030] Step 1, add an organic solvent 1 and an organic base into a reaction bottle, then add 3-amino-1-adamantanol (Formula II) and (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile (Formula III), heat to 40-55° C., react for 10-12 hours, and obtain a reaction solution;
[0031] Step 2, subjecting the reaction solution obtained in the above step 1 to reduced pressure distillation, cooling it to 30-45° C., adding organic solvent 2 and adsorbent, and stirring for 1-2 hours;
[0032] Step 3, after the stirring in the above step 2, the mixture is allowed to stand for stratification, and the filter residue is washed with an organic solvent to obtain an organic phase extract;
[0033] Step 4, adding a desiccant to the organic phase extract obtained in the above step 3 for drying, filtering and concentrating under reduced pressure to obtain a concentrated solution;
[0034] Step 5: Add organic solvent 2 to the concentrated solution obtained in step 4, heat until completely dissolved, cool to 0-3°C for crystallization, filter, and vacuum dry to obtain vildagliptin (Formula I).
[0035] Preferably, the organic solvent 1 in step 1 is one or a combination of more than one of tetrahydrofuran, dimethylacetamide, dichloromethane, ethyl acetate, methanol and acetone.
[0036] Preferably, a catalyst is also added to the reaction flask in step 1, and the catalyst is potassium iodide.
[0037] Preferably, the organic base in step 1 is one or a combination of more than one of potassium carbonate, triethylamine, tetramethylguanidine and pyridine.
[0038] Preferably, the molar ratio of 3-amino-1-adamantanol to (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile is 1.0-2.0:0.5-1.2.
[0039] Preferably, the organic solvent is one or a combination of more than one of toluene, dichloromethane, chloroform, ethyl acetate, methanol, ethanol, isopropanol, acetone and butanone.
[0040] Preferably, the adsorbent is one or a combination of more than one of basic alumina and silica gel.
[0041] Preferably, the desiccant is one or a combination of more than one of anhydrous magnesium sulfate, anhydrous sodium sulfate, anhydrous calcium chloride, phosphorus pentoxide, and anhydrous potassium carbonate.
[0042] Preferably, the vacuum drying conditions in step 5 are: vacuum drying at 40-50° C. for 5-8 hours.
[0043] Embodiment 1:
[0044] 1. Add 100 mL of tetrahydrofuran, 2 g of potassium carbonate, 50 g of potassium iodide, 30 g of 3-amino-1-adamantanol and slowly drop 20 g of (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile tetrahydrofuran solution into a reaction bottle, heat to 45 ° C, react for 10 hours, and obtain a reaction solution.
[0045] 2. The reaction solution obtained in step 1 was subjected to reduced pressure distillation and cooled to 30° C. 40 mL of methanol and 100 g of basic alumina were added and stirred for 2 h.
[0046] 3. After stirring in step 2, the mixture was allowed to stand for stratification, and the filter residue was washed with 10 mL of methanol to obtain an organic phase extract;
[0047] 4. Add 50 g of anhydrous magnesium sulfate to the organic phase extract obtained in step 3 above for drying, filter and concentrate under reduced pressure to obtain a concentrated solution;
[0048] 5. Add 10 mL of methanol to the concentrated solution obtained in step 4 above, heat until completely dissolved, cool to 0-3°C for crystallization, filter, and vacuum dry at 40°C for 8 h to obtain vildagliptin.
[0049] Embodiment 2:
[0050] 1. Add 100 mL of methanol, 2 g of triethylamine, 50 g of potassium iodide, 40 g of 3-amino-1-adamantanol, and slowly drop 30 g of (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile tetrahydrofuran solution 50 mL into a reaction bottle, heat to 50 ° C, react for 12 hours, and obtain a reaction solution.
[0051] 2. The reaction solution obtained in step 1 was subjected to reduced pressure distillation and cooled to 30°C. 40 mL of acetone and 100 g of silica gel were added and stirred for 2 h.
[0052] 3. After stirring in step 2, the mixture was allowed to stand for stratification, and the filter residue was washed with 10 mL of acetone to obtain an organic phase extract;
[0053] 4. Add 50 g of anhydrous magnesium sulfate to the organic phase extract obtained in step 3 above for drying, filter and concentrate under reduced pressure to obtain a concentrated solution;
[0054] 5. Add 10 mL of acetone to the concentrated solution obtained in step 4 above, heat until completely dissolved, cool to 0-3°C for crystallization, filter, and vacuum dry at 50°C for 6 h to obtain vildagliptin.
[0055] Embodiment 3:
[0056] 1. Add 100 mL of acetone, 2 g of tetramethylguanidine, 50 g of potassium iodide, 50 g of 3-amino-1-adamantanol, and slowly drop 40 g of (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile tetrahydrofuran solution into a reaction bottle, heat to 50 ° C, react for 12 hours, and obtain a reaction solution.
[0057] 2. The reaction solution obtained in step 1 was subjected to reduced pressure distillation and cooled to 30°C. 40 mL of ethyl acetate and 100 g of silica gel were added and stirred for 2 h.
[0058] 3. After stirring in step 2, the mixture was allowed to stand for stratification, and the filter residue was washed with 10 mL of ethyl acetate to obtain an organic phase extract;
[0059] 4. Add 50 g of anhydrous magnesium sulfate to the organic phase extract obtained in step 3 above for drying, filter and concentrate under reduced pressure to obtain a concentrated solution;
[0060] 5. Add 10 mL of ethyl acetate to the concentrated solution obtained in step 4 above, heat until completely dissolved, cool to 0-3°C for crystallization, filter, and vacuum dry at 50°C for 8 h to obtain vildagliptin.
[0061] The vildagliptin finished product obtained by the purification method of the present invention can control the vildagliptin disubstituted impurities to be below 0.10%.
[0062] The invention can avoid multiple recrystallization refining and greatly improve the yield, which is greater than 90%.
[0063] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. It should be pointed out that a person skilled in the art can make several improvements and modifications without departing from the technical principles of the present invention, and these improvements and modifications should also be regarded as within the scope of protection of the present invention.
Claims
1. A method for purifying vildagliptin, characterized in that: The purification method comprises the following steps in sequence: Step 1, add an organic solvent 1 and an organic base into a reaction bottle, then add 3-amino-1-adamantanol and (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile, heat to 40-55° C., react for 10-12 hours, and obtain a reaction solution; Step 2, subjecting the reaction solution obtained in the above step 1 to reduced pressure distillation, cooling it to 30-45° C., adding organic solvent 2 and adsorbent, and stirring for 1-2 hours; Step 3, after the stirring in the above step 2, the mixture is allowed to stand for stratification, and the filter residue is washed with an organic solvent to obtain an organic phase extract; Step 4, adding a desiccant to the organic phase extract obtained in the above step 3 for drying, filtering and concentrating under reduced pressure to obtain a concentrated solution; Step 5: Add organic solvent 2 to the concentrated solution obtained in step 4, heat until completely dissolved, cool to 0-3°C for crystallization, filter, and vacuum dry to obtain vildagliptin.
2. The method for purifying vildagliptin according to claim 1, wherein The organic solvent 1 in step 1 is one or a combination of more than one of tetrahydrofuran, dimethylacetamide, dichloromethane, ethyl acetate, methanol and acetone.
3. The method for purifying vildagliptin according to claim 1, wherein: A catalyst is also added to the reaction bottle in step 1, and the catalyst is potassium iodide.
4. The method for purifying vildagliptin according to claim 1, wherein The organic base in step 1 is one or a combination of more than one of potassium carbonate, triethylamine, tetramethylguanidine and pyridine.
5. The method for purifying vildagliptin according to claim 1, wherein: The molar ratio of the 3-amino-1-adamantanol to the (S)-1-(2-chloroacetyl)pyrrole-2-carbonitrile is 1.0-2.0:0.5-1.
2.
6. The method for purifying vildagliptin according to claim 1, wherein: The second organic solvent is one or a combination of more than one of toluene, dichloromethane, chloroform, ethyl acetate, methanol, ethanol, isopropanol, acetone and butanone.
7. The method for purifying vildagliptin according to claim 1, characterized in that: The adsorbent is one or a combination of more than one of alkaline alumina and silica gel.
8. The method for purifying vildagliptin according to claim 1, wherein: The desiccant is one or a combination of more than one of anhydrous magnesium sulfate, anhydrous sodium sulfate, anhydrous calcium chloride, phosphorus pentoxide, and anhydrous potassium carbonate.
9. The method for purifying vildagliptin according to claim 1, characterized in that: The vacuum drying conditions in step 5 are: vacuum drying at 40-50° C. for 5-8 hours.
Citation Information
Patent Citations
Process for preparing Vildagliptin by one-pot method
CN102617434A
